Mind Medicine (MindMed) Inc. Stock Other OTC
Equities
MMEDF
CA60255C1095
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 652M 887M |
---|---|---|---|---|---|
Net income 2024 * | -123M -167M | Net income 2025 * | -106M -144M | EV / Sales 2024 * | - |
Net cash position 2024 * | 185M 252M | Net cash position 2025 * | 100M 136M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.96
x | P/E ratio 2025 * |
-6.34
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.24% |
Latest transcript on Mind Medicine (MindMed) Inc.
Managers | Title | Age | Since |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | 35 | 21-01-13 |
Miri Wernli
PSD | President | 71 | 20-02-27 |
Daniel Karlin
CTO | Chief Tech/Sci/R&D Officer | 44 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 65 | 21-09-28 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 22-08-10 |
David Gryska
BRD | Director/Board Member | 68 | 23-06-20 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |